Renal Insufficiency, Chronic Clinical Trial
Official title:
Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients
The purpose of this project is to test the efficacy of Planet K, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' chronic kidney disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet K mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in adolescents and young adults with chronic kidney disease (CKD).
Advances in medical treatment options over the past several decades have translated into
substantially higher survival rates for those who suffer with chronic illness. Consequently,
the prevalence of chronic illness has risen significantly in recent years, such that one out
of every four youth in the United States currently lives with a chronic illness. The health
and well-being of these youth is directly impacted by the degree to which they adhere to
their treatment regimen. However, treatment regimens for chronic illness can be highly
complex, making adherence problematic, particularly when combined with deficits in memory
and executive functioning concomitant with many chronic illnesses. Adherence also tends to
deteriorate over time; the youth's motivation or commitment to treatment may decline as
symptoms improve or negative side effects occur. With low adherence comes worsening symptoms
and significantly greater risk for serious medical complications and mortality in young
adulthood. The costs associated with low adherence, such as the need for additional care,
are also substantial both for the patient and society.
While a number of factors have been found to impact treatment adherence, risk for
non-adherence—across varied forms of chronic illness—is markedly elevated when the youth
lacks disease- and treatment-related knowledge and when parents provide little supervision
for carrying out regimen tasks. With nearly 90% of youth with chronic illness expected to
survive and therefore transition from pediatric care into adult-focused healthcare systems,
it is critically important to empower youth to take ownership of their own healthcare. To do
so, tools there is a need to provide accessible, affordable tools that can effectively
increase patients' skills and knowledge for managing their illness and support on-going
adherence to their treatment regimen.
The purpose of this project is to test the efficacy of Planet K, a mobile and web-based
technology infrastructure specifically designed to (a) enhance youths' chronic kidney
disease- and treatment-related knowledge through interactive and game-based educational
materials; (b) support adherence to the treatment regimen through customized task prompts
via mobile and web-based delivery; and (c) promote patient-provider communication through
real-world data collection and feedback loops. Investigators will examine the effectiveness
of the Planet K mobile app and website in improving treatment adherence, disease-related
knowledge, transition readiness, condition management, and the psychological correlates of
these variables in adolescents and young adults with chronic kidney disease (CKD).
All participants will complete study measures at pre- and post-assessment time points. In
total, participants will take part in this study for approximately 2 months from pre- to
post-assessment. Families will be recruited to participate in either the treatment condition
or the control group. Families in the treatment condition will receive the Planet K app and
access to the associated website for the full duration of the study (4 months) between
pre-test and post-test. Families in the control group will not receive access to the app and
website but instead will be asked to complete a series of online questionnaires at each of
the two data collection time points (pre-test, post-test).
Investigators hypothesize that greater use (i.e., dosage) and prolonged use of Planet K
will: increase disease-related knowledge, treatment adherence, self-efficacy for management
of CKD, current CKD self-management behaviors, perceived severity of CKD, readiness to
transition to independent self-care, and perceived benefits of CKD treatment, while also
decreasing perceived barriers to CKD treatment. Moreover, investigators believe that
improvement of these outcomes through use of Planet K will result in more positive mental
health outcomes for participants, including lower depression and higher reported quality of
life. Investigators expect that those in the treatment condition will have better outcomes
than those in the control group on all of these measures at both midpoint and
post-assessment time points. Finally, investigators expect all participants to report high
usability, quality, and value of the Planet K mobile app and website and to positively rate
their experience with Planet K.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05056727 -
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
|
Phase 3 | |
Withdrawn |
NCT01655186 -
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT03481686 -
Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections
|
N/A | |
Active, not recruiting |
NCT03672110 -
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
|
Phase 3 | |
Enrolling by invitation |
NCT02237534 -
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
|
Phase 4 | |
Completed |
NCT02126293 -
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
|
Phase 3 | |
Terminated |
NCT01533545 -
Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
|
N/A | |
Completed |
NCT03280615 -
Omega 3 Fatty Acids in Patients With Chronic Renal Disease
|
Phase 3 | |
Completed |
NCT04498156 -
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
|
||
Recruiting |
NCT04020328 -
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
|
Phase 4 | |
Recruiting |
NCT06366529 -
Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction
|
||
Active, not recruiting |
NCT04876963 -
HOLT-ED: Holter-monitoring in End-stage Renal Disease
|
||
Completed |
NCT03836508 -
Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis
|
N/A | |
Completed |
NCT03250715 -
Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure
|
N/A | |
Completed |
NCT03577249 -
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
|
Phase 2/Phase 3 | |
Completed |
NCT01975818 -
Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
|
Phase 2 | |
Active, not recruiting |
NCT05766644 -
App-based Education Program for CKD
|
N/A | |
Active, not recruiting |
NCT02791880 -
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
|
||
Recruiting |
NCT02947750 -
Neurovascular Transduction During Exercise in Chronic Kidney Disease
|
Phase 2 | |
Terminated |
NCT02286258 -
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
|
Phase 1/Phase 2 |